Ataraxia
0846.408.934 · rovalta.com · 07/11/2026
NORMAL SITUATION
Ataraxia
Company — Normal situation.
Financial year 2022 · Closed on 30/09/2022
Net result-37,8 k €-133,6 %over 1 year
Gross margin-37,4 k €-20,2 %over 1 year
Equity39,7 k €-48,8 %over 1 year
Overview
Identity
Source · BCE/KBOAtaraxia is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0846.408.934
- Legal form
- Private company with limited liability
- Contributed capital
- 12 750,00 €
- Latest accounts
- 30/09/2022
Signals
Solid equityGood liquidity
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -37,4 k € | -20.2% | -31,1 k € | -221% | 25,7 k € | +262% | 7,1 k € | +384% | 1,5 k € |
| EBITDA | -37,8 k € | -16.5% | -32,5 k € | -271% | 19 k € | +188% | 6,6 k € | +625% | 910,5 € |
| Operating result | -37,8 k € | -9.1% | -34,7 k € | -307% | 16,7 k € | +238% | 4,9 k € | +196% | -5,2 k € |
| Net result | -37,8 k € | -134% | 112,5 k € | +567% | 16,9 k € | +245% | 4,9 k € | +191% | -5,3 k € |
| Balance sheet | |||||||||
| Equity | 39,7 k € | -48.8% | 77,6 k € | +322% | -35 k € | +32.5% | -51,8 k € | +8.6% | -56,7 k € |
| Total assets | 122,7 k € | -42.4% | 213,1 k € | +253% | 60,4 k € | +109% | 28,9 k € | +5.1% | 27,5 k € |
| Cash | 122,5 k € | +2317% | 5,1 k € | -87.8% | 41,7 k € | +3886% | 1 k € | -73.6% | 4 k € |
| Debts | 82,9 k € | -38.8% | 135,5 k € | +42.0% | 95,4 k € | +39.0% | 68,7 k € | -18.5% | 84,3 k € |
Board of directors
Source · NBB, accounts to 30/09/20221 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
André Duval | Directorsince 07/06/2012Manager06/06/2012 → 2016 accountsended |
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 | 01/10/2017 | 01/10/2016 |
| Closing of the financial year | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 | 30/09/2018 | 30/09/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/06/2023 | 29/04/2022 | 30/04/2021 | 30/04/2020 | 30/04/2019 | 29/03/2018 |
| General meeting | 16/12/2022 | 17/12/2021 | 18/12/2020 | 20/12/2019 | 21/12/2018 | 15/12/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2022 | 16/12/2022 | 13/06/2023 | Dutch | |
| Micro model | 30/09/2021 | 17/12/2021 | 29/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 18/12/2020 | 30/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 20/12/2019 | 30/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 21/12/2018 | 30/04/2019 | Dutch | |
| Micro model | 30/09/2017 | 15/12/2017 | 29/03/2018 | Dutch | |
| Abridged model | 30/09/2016 | 16/12/2016 | 31/03/2017 | Dutch | |
| Abridged model | 30/09/2015 | 18/12/2015 | 25/05/2016 | Dutch | |
| Abridged model | 30/09/2014 | 13/03/2015 | 25/03/2015 | Dutch | |
| Abridged model | 30/09/2013 | 20/12/2013 | 25/08/2014 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20221 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
André Duval | Directorsince 07/06/2012Manager06/06/2012 → 2016 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings10 filings
Mandates
André Duval
201220132014201520162017201820192020202120222023202420252026
Spanjaardsteeg 21/4.2, 2000 Antwerp
DirectorManager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Spanjaardsteeg 21/4.2, 2000 Antwerp | accounts 2021 → 2022 | Accounts 2022 · 2023-00122063 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Ataraxia in vereffening | accounts 2022 | Accounts 2022 · 2023-00122063 |
| Ataraxia | accounts 2021 | Accounts 2021 · 2022-20013074 |
Events
- 2022Annual accounts 2022-37,8 k €↓
- 2022Name changeAtaraxia in vereffening
- 2021Annual accounts 2021112,5 k €↑
- 2020Annual accounts 202016,9 k €↑
- 2019Annual accounts 20194,9 k €↑
- 2018Annual accounts 2018-5,3 k €↑
- 2017Annual accounts 2017-31,8 k €↓
- 2016Annual accounts 2016-31,7 k €↓
- 2015Annual accounts 2015-23,5 k €↓
- 2014Annual accounts 201424,7 k €↑
- 2013Annual accounts 2013-1,8 k €